BioStem said the acquisition will support its advancement into ‘high value’ adjacent market segments.

An estimated 10.5 million people across the U.S. live with chronic wounds that are difficult to heal.

BioTissue Holdings, Inc, a leader in harnessing the unique properties of human birth tissue to facilitate regenerative ...

Key Players Covered in the Smith & Nephew (U.K.), mölnlycke Health Care AB (Sweden), 3M (U.S.), ConvaTec Group PLC (U.K.), Tissue Regenix (U.S.), B. Braun Melsungen AG (Germany), Integra LifeSciences ...

An effective treatment for chronic wounds that does not involve antibiotics, but an ionized gas to activate a wound dressing, has been developed by a team of international scientists. The treatment ...

Individuals increasingly can check on their health conditions at home. Devices that measure blood pressure, glucose and blood oxygen levels, for example, enable patients’ providers to make decisions ...

New method provides information on spatial heat distribution in a wound to accurately predict whether VLUs will heal. The clinical study is the first to investigate textural analysis on VLUs using ...

PHOENIX, Oct. 29, 2025 /PRNewswire/ -- BioLab Holdings, Inc. a Phoenix-based medical manufacturer specializing in wound care solutions, announced the ongoing development of several clinical trials ...

INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...